Erythropoietin for hemoglobin H disease

Annals of Hematology

Volumn 88, Issue 2, 2009, Pages 179-180

  Fortenko, Olga M ^a   Schaef Johns, Gretchen J ^a   Kudva, Ganesh C ^a,b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAINT LOUIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GLOBIN; HEMOGLOBIN A; HEMOGLOBIN A2; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN;

ADULT; ANEMIA; BLOOD DISEASE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; ERYTHROCYTE TRANSFUSION; FATIGUE; FEMALE; GENE DELETION; GENETIC ANALYSIS; GENETIC DISORDER; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN H DISEASE; HEPATOSPLENOMEGALY; HUMAN; LETTER; PRIORITY JOURNAL; RETICULOCYTE COUNT;

ADULT; ALPHA-THALASSEMIA; ERYTHROPOIETIN; FEMALE; HEMOGLOBINS; HUMANS;

EID: 58149092124     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-008-0556-y     Document Type: Letter

References (11)

1. Dozy AM, Kan YW, Embury SH, Mentzer WC, Wang WC (1979) a-Globin gene organization in blacks precludes the severe form of a-thalassemia. Nature 280(5723):605-607 doi: 10.1038/280605a0
2. Phillips JA III, Vik TA, Scott AF, Young KE, Kazazian HH Jr, Smith KD et al (1980) Unequal crossing-over: A common basis of single a-globin genes in Asians and American Blacks with Hemoglobin H disease. Blood 55(6):1066-1069
3. Chui DH, Fucharoen S, Chan V (2003) Hemoglobin H disease: Not necessarily a benign disorder. Blood 101(3):791-800 doi: 10.1182/ blood-2002-07-1975
4. Wasi P, Na-Nakorn, Pootrakul S (1974) The a-thalassaemias. Clin Haematol 3(2):383-410
5. Ne-Win, Harano K, Harano T, Thein-Thein-Myint, Rai-Mra, Aye-Aye-Myint, Shimono K, Okada S (2006) Common a-thalassemia deletions in transfusion-dependent thalassemia patients in the Southeast Asia region of Myanmar. Lab Hematol 12(3):139-142 doi: 10.1532/LH96.06017
6. Origa R, Sollaino MC, Giagu N, Barella S, Campus S, Mandas C et al (2007) Clinical and molecular analysis of hemoglobin H disease in Sardinia: Hematological, obstetric and cardiac aspects in patients with different genotypes. Br J Haematol 136(2):326-332 doi: 10.1111/ j.1365-2141.2006.06423.x
7. Kanavakis E, Papassotiriou I, Karagiorga M, Vrettou C, Metaxotou-Mavrommati A, Stamoulakatou A et al (2000) Phenotypic and molecular diversity of hemoglobin H disease: A Greek experience. Br J Haematol 111(3):915-923 doi: 10.1046/j.1365-2141.2000.02448.x
8. Winearls CG, Hughes RT, Pippard MJ, Cotes PM (1992) Erythropoietin dose requirement in a patient with HbH disease and renal failure. Nephrol Dial Transplant 7(10):1052-1054
9. Chaidos A, Makis A, Hatzimichael E, Tsiara S, Gouva M, Tzouvara E et al (2004) Treatment of b-thalassemia patients with recombinant human erythropoietin: Effect on transfusion requirements and soluble adhesion molecules. Acta Haematol 111(4):189-195 doi: 10.1159/000077551
10. Nisli G, Kavakli K, Aydinok Y, Oztop S, Cetingul N, Basak N (1997) Recombinant erythropoietin trial in children with transfusion-dependent homozygous b-thalassemia. Acta Haematol 98(4):199-203
11. Papassotiriou I, Traeger-Synodinos J, Kanavakis E, Karagiorga M, Stamoulakatou A, Kattamis C (1998) Erythroid marrow activity and hemoglobin H levels in hemoglobin H disease. J Pediatr Hematol Oncol 20(6):539-544 doi: 10.1097/00043426-199811000-00006